Gianni Allais

Dr. Gianni Allais


Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2009
Verified
Reference Entry
Open access
PDF file
KLKlaus Linde
Klaus Linde
GAGianni Allais
Gianni Allais
BBBenno Brinkhaus
Benno Brinkhaus
EMEric Manheimer
Eric Manheimer
AVAndrew J. Vickers
Andrew J. Vickers
AWAdrian R White
Adrian R White
Background Acupuncture is often used for migraine prophylaxis but its effectiveness is still controversial. This review (along with a companion review on 'Acupuncture for tension‐type headache') represents an updated version of a Cochrane review originally published in Issue 1, 2001, of The Cochrane Library. Objectives To investigate whether acupuncture is a) more effective than no prophylactic treatment/routine care only; b) more effective than 'sham' (placebo) acupuncture; and c) as effective as other interventions in reducing headache frequency in patients with migraine. Search methods The Cochrane Pain, Palliative & Supportive Care Trials Register, CENTRAL, MEDLINE, EMBASE and the Cochrane Complementary Medicine Field Trials Register were searched to January 2008. Selection criteria We included randomized trials with a post‐randomization observation period of at least 8 weeks that compared the clinical effects of an acupuncture intervention with a control (no prophylactic treatment or routine care only), a sham acupuncture intervention or another intervention in patients with migraine. Data collection and analysis Two reviewers checked eligibility; extracted information on patients, interventions, methods and results; and assessed risk of bias and quality of the acupuncture intervention. Outcomes extracted included response (outcome of primary interest), migraine attacks, migraine days, headache days and analgesic use. Pooled effect size estimates were calculated using a random‐effects model. Main results Twenty‐two trials with 4419 participants (mean 201, median 42, range 27 to 1715) met the inclusion criteria. Six trials (including two large trials with 401 and 1715 patients) compared acupuncture to no prophylactic treatment or routine care only. After 3 to 4 months patients receiving acupuncture had higher response rates and fewer headaches. The only study with long‐term follow up saw no evidence that effects dissipated up to 9 months after cessation of treatment. Fourteen trials compared a 'true' acupuncture intervention with a variety of sham interventions. Pooled analyses did not show a statistically significant superiority for true acupuncture for any outcome in any of the time windows, but the results of single trials varied considerably. Four trials compared acupuncture to proven prophylactic drug treatment. Overall in these trials acupuncture was associated with slightly better outcomes and fewer adverse effects than prophylactic drug treatment. Two small low‐quality trials comparing acupuncture with relaxation (alone or in combination with massage) could not be interpreted reliably. Authors' conclusions In the previous version of this review, evidence in support of acupuncture for migraine prophylaxis was considered promising but insufficient. Now, with 12 additional trials, there is consistent evidence that acupuncture provides additional benefit to treatment of acute migraine attacks only or to routine care. There is no evidence for an effect of 'true' acupuncture over sham interventions, though this is difficult to interpret, as exact point location could be of limited importance. Available studies suggest that acupuncture is at least as effective as, or possibly more effective than, prophylactic drug treatment, and has fewer adverse effects. Acupuncture should be considered a treatment option for patients willing to undergo this treatment.

26 August 2020 in Neurological Sciences
Verified
Journal Article
Open access
PDF file
GAGianni Allais
Gianni Allais
GCGiulia Chiarle
Giulia Chiarle
SSSilvia Sinigaglia
Silvia Sinigaglia
GAGisella Airola
Gisella Airola
PSPaola Schiapparelli
Paola Schiapparelli
CBChiara Benedetto
Chiara Benedetto
Migraine is considered mostly a woman’s complaint, even if it affects also men. Epidemiological data show a higher incidence of the disease in women, starting from puberty throughout life. The sex-related differences of migraine hold clinical relevance too. The frequency, duration, and disability of attacks tend to be higher in women. Because of this, probably, they also consult specialists more frequently and take more prescription drugs than men. Different mechanisms have been evaluated to explain these differences. Hormonal milieu and its modulation of neuronal and vascular reactivity is probably one of the most important aspects. Estrogens and progesterone regulate a host of biological functions through two mechanisms: nongenomic and genomic. They influence several neuromediators and neurotransmitters, and they may cause functional and structural differences in several brain regions, involved in migraine pathogenesis. In addition to their central action, sex hormones exert rapid modulation of vascular tone. The resulting specific sex phenotype should be considered during clinical management and experimental studies.

1 September 2004 in Cephalalgia
Verified
Journal Article
Closed access
PDF file
FGF Granella
F Granella
GSG Sances
G Sances
GAGianni Allais
Gianni Allais
RNRe Nappi
Re Nappi
ATA Tirelli
A Tirelli
GNG Nappi
G Nappi

21 January 2009
Verified
Reference Entry
Closed access
PDF file
KLKlaus Linde
Klaus Linde
GAGianni Allais
Gianni Allais
BBBenno Brinkhaus
Benno Brinkhaus
EMEric Manheimer
Eric Manheimer
AVAndrew J. Vickers
Andrew J. Vickers
AWAdrian R White
Adrian R White

1 November 1999 in Cephalalgia
Verified
Journal Article
Open access
DMD Melchart
D Melchart
KLK Linde
K Linde
PFP Fischer
P Fischer
AWA White
A White
GAGianni Allais
Gianni Allais
BBB Berman
B Berman
Objective: To assess whether there is evidence that acupuncture is effective in the treatment of recurrent headaches. Design: Systematic review. Study selection: Randomized or quasi-randomized clinical trials comparing acupuncture with any type of control intervention for the treatment of recurrent headaches. Data sources: Electronic databases (Medline, Embase, Cochrane Field for Complementary Medicine, Cochrane Controlled Trials Register), personal communications and bibliographies. Data collection and analysis: Information on patients, interventions, methods, and results were extracted by at least two independent reviewers using a pretested form. A pooled estimate of the responder rate ratio (responder rate in treatment group/responder rate in control group) was calculated as a crude indicator of trial results as meta-analysis of more specific outcome data was impossible due to heterogeneity and insufficient reporting. Results: Twenty-two trials, including a total of 1042 patients (median 36, range 10-150), met the inclusion criteria. Fifteen trials were in migraine patients, six in tension-headache patients, and in one trial patients with various headaches were included. The majority of the 14 trials comparing true and sham acupuncture showed at least a trend in favor of true acupuncture. The pooled responder rate ratio was 1.53 (95% confidence interval 1.11 to 2.11). The eight trials comparing acupuncture and other treatment forms had contradictory results. Conclusions: Overall, the existing evidence suggests that acupuncture has a role in the treatment of recurrent headaches. However, the quality and amount of evidence is not fully convincing. There is urgent need for well-planned, large-scale studies to assess effectiveness and efficiency of acupuncture under real life conditions.

1 December 2007 in The Lancet Neurology
Verified
Journal Article
Closed access
HDHans-Christoph Diener
Hans-Christoph Diener
RAReto Agosti
Reto Agosti
GAGianni Allais
Gianni Allais
PBPaul Bergmans
Paul Bergmans
GBGennaro Bussone
Gennaro Bussone
JOJoop van Oene
Joop van Oene